These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

950 related items for PubMed ID: 3926987

  • 1. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR, Napier TC, Mueller RA.
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [Abstract] [Full Text] [Related]

  • 2. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 3. Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine.
    Breese GR, Baumeister A, Napier TC, Frye GD, Mueller RA.
    J Pharmacol Exp Ther; 1985 Nov; 235(2):287-95. PubMed ID: 3932640
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors.
    Breese GR, Criswell HE, McQuade RD, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1990 Feb; 252(2):558-67. PubMed ID: 1968972
    [Abstract] [Full Text] [Related]

  • 5. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 6. Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine.
    Duncan GE, Criswell HE, McCown TJ, Paul IA, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1027-34. PubMed ID: 3121842
    [Abstract] [Full Text] [Related]

  • 7. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
    Huang KX, Walters JR.
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB, Criswell HE, Jensen KF, Simson PE, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
    [Abstract] [Full Text] [Related]

  • 9. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.
    Carlson JH, Bergstrom DA, Demo SD, Walters JR.
    Synapse; 1990 Aug; 5(2):83-93. PubMed ID: 2309160
    [Abstract] [Full Text] [Related]

  • 10. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

  • 11. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR, Baumeister AA, McCown TJ, Emerick SG, Frye GD, Crotty K, Mueller RA.
    J Pharmacol Exp Ther; 1984 Nov 10; 231(2):343-54. PubMed ID: 6149306
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
    Imperato A, Tanda G, Frau R, Di Chiara G.
    J Pharmacol Exp Ther; 1988 Apr 10; 245(1):257-64. PubMed ID: 3258912
    [Abstract] [Full Text] [Related]

  • 13. Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats.
    Arnt J, Hyttel J.
    Psychopharmacology (Berl); 1985 Apr 10; 85(3):346-52. PubMed ID: 2860689
    [Abstract] [Full Text] [Related]

  • 14. Assessment of purine-dopamine interactions in 6-hydroxydopamine-lesioned rats: evidence for pre- and postsynaptic influences by adenosine.
    Criswell H, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1988 Feb 10; 244(2):493-500. PubMed ID: 3126293
    [Abstract] [Full Text] [Related]

  • 15. Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesions.
    Arnt J.
    Life Sci; 1985 Aug 26; 37(8):717-23. PubMed ID: 3927097
    [Abstract] [Full Text] [Related]

  • 16. Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment.
    Brus R, Kostrzewa RM, Perry KW, Fuller RW.
    J Pharmacol Exp Ther; 1994 Jan 26; 268(1):231-7. PubMed ID: 8301563
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice.
    Shannon HE, Peters SC.
    J Pharmacol Exp Ther; 1990 Nov 26; 255(2):549-53. PubMed ID: 2243341
    [Abstract] [Full Text] [Related]

  • 18. Local cerebral glucose utilization after D1 receptor stimulation in 6-OHDA lesioned rats: effect of sensitization (priming) with a dopaminergic agonist.
    Morelli M, Pontieri FE, Linfante I, Orzi F, Di Chiara G.
    Synapse; 1993 Mar 26; 13(3):264-9. PubMed ID: 8098880
    [Abstract] [Full Text] [Related]

  • 19. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS, Joyce JN.
    Dev Psychobiol; 1998 May 26; 32(4):313-26. PubMed ID: 9589220
    [Abstract] [Full Text] [Related]

  • 20. SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.
    Breese GR, Mueller RA.
    Eur J Pharmacol; 1985 Jul 11; 113(1):109-14. PubMed ID: 2864260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.